about
Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to ArtemisininsArtemisinins: their growing importance in medicineGeographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversityIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesStatus of potential PfATP6 molecular markers for artemisinin resistance in SurinameMolecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies.Genetic diversity and lack of artemisinin selection signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion.Discovery, mechanisms of action and combination therapy of artemisininMolecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxiLack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins.Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian AmazonExamining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionRapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum.Characterization of the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase gene in samples from Equatorial Guinea before implementation of artemisinin-based combination therapy.Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy.Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assaysResistance to dihydroartemisinin.New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam.
P2860
Q22061846-89764CC2-26D9-447E-B64D-921AD74FA77AQ27489880-2323ECA0-85B9-41E2-B549-51026F212A30Q28473014-9154DB85-0E5E-4629-8336-379A50AE1A37Q28484068-9B9E454B-0875-40BA-820D-7F09497FCB20Q29353788-A74976A0-2656-48ED-90C2-197456FBCCCBQ33721915-4A4BFA60-DC3A-4FBB-B117-C540D20D4733Q34068703-0CFC9508-9115-40BB-8555-C35BBCAA3FE5Q34483513-1EB8DB5B-F7CC-4871-BE99-0EA62152930BQ34650827-DDE9E210-6CD3-4C4A-89CF-F018101B7164Q35006418-708C5207-1D6E-42FE-88A0-6F94BD9F9122Q35065564-AB813722-EBE2-496E-B8D5-93EAC60BFF66Q35941360-9D11979D-1FCD-42B0-AA20-E91974A4F9C1Q35953474-BF0691B2-FE51-4B81-A1C3-8FAB697B93F7Q35991544-C659D91F-D958-40C0-8878-628ED97D1D64Q36018682-828FF4BB-E160-4C0C-AA66-BAFAB7BE6BA4Q36523053-4AFD72FA-D8D9-4FCD-B01F-385A84CD8B1FQ36556442-05310FFB-2D7F-4833-BEF2-D84D14315A97Q37126331-73F8A4F4-B728-4015-A939-51E596ED688CQ37184295-96E409FD-3EB1-47D7-B21D-197BCECB56E2Q42546938-E96449E2-7EA8-4DF2-AA77-FEDA475CF79BQ42586781-112800A9-DD20-4FF0-A684-D1A9698AECE5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Resistance to dihydroartemisinin.
@en
Resistance to dihydroartemisinin.
@nl
type
label
Resistance to dihydroartemisinin.
@en
Resistance to dihydroartemisinin.
@nl
prefLabel
Resistance to dihydroartemisinin.
@en
Resistance to dihydroartemisinin.
@nl
P2860
P356
P1476
Resistance to dihydroartemisinin.
@en
P2093
Rémy Durand
Véronique Hubert
P2860
P304
P356
10.3201/EID1211.060903
P577
2006-11-01T00:00:00Z